Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: Results of a trial comparing ertapenem and piperacillin-tazobactam

Journal of Chemotherapy

Volumn 16, Issue 1, 2004, Pages 62-69

  Teppler, H ^a   Meibohm, A R ^a   Woods, G L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Appendicitis; Clinical trial; Ertapenem

Indexed keywords

ERTAPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL INFECTION; ABSCESS DRAINAGE; ADULT; AGED; APPENDICITIS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PERCUTANEOUS DRAINAGE; PERITONITIS; POSTOPERATIVE INFECTION; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME;

EID: 1942423082     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.1.62     Document Type: Article

References (21)

1. Allo MD, Bennion RS, Kathir K, et al. Ticarcillin/clavulanate versus imipenem/cilistatin for the treatment of infections associated with gangrenous and perforated appendicitis. Am Surg 1999; 65: 99-104.
2. Heseltine PNR, Yellin AE, Appleman MD, et al. Imipenem therapy for perforated and gangrenous appendicitis. Surg Gynecol Obstet 1986; 162: 43-8.
3. Heseltine PNR, Yellin AE, Appleman MD, Gill MA, Chenella FC, Berne TV. Perforated and gangrenous appendicitis: an analysis of antibiotic failures. J Infect Dis 148; 322: 1983.
4. Bennion RS, Thompson JE, Baron EJ, Finegold SM. Gangrenous and perforated appendicitis with peritonitis: treatment and bacteriology. Clin Therapeut 1990; 12 (Suppl. C): 31-44.
5. Berne TV, Yellin AE, Appleman MD, Heseltine PNR., Gill MA. Meropenem versus tobramycin with clindamycin in the antibiotic management of patients with advanced appendicitis. J Am Coll Surg 1996; 182: 403-7.
6. Bohnen JMA, Solomkin JS, Dellinger EP, Bjornson HS, Page CP. Guidelines for critical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement. Arch Surg 1992; 127: 83-9.
7. Mazuski JE, Sawyer RG, Nathens AB, et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect 2002; 3: 161-73.
8. Barie PS. Management of complicated intra-abdominal infections. J Chemother 1999; 11: 464-77.
9. Fuchs PC, Barry AL, Brown SD. In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers. Antimicrob Agents Chemother 2001; 45: 1915-8.
10. Aldridge K. Ertapenem (MK-0826), a new carbapenem: comparative in vitro activity against clinically significant anaerobes. Diagn Microbiol Infect Dis 2002; 44: 181-6.
11. Friedland I, Mixson LA, Majumdar A, Motyl M, Woods GL. In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics. J Chemother 2002; 14: 483-91.
12. Solomkin JS, Yellin AE, Rotstein OD, et al. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: Results of a double-blind, randomized comparative phase III trial. Ann Surg 2003; 237: 235-45.
13. Beam TR. Jr, Gilbert DN, Kunin DM. General guidelines for the clinical evaluation of anti-infective drug products. Clin Infect Dis 1992; 15 (Suppl 1): S5-32.
14. th ed. NCCLS document M7-A5. Wayne, PA: National Committee for Clinical Laboratory Standards, 2000.
15. th ed. Approved Standard, M11-A5. Wayne, PA: National Committee for Clinical Laboratory Standards, 2001.
16. Teppler H, Gesser RM, Friedland IR, et al. Safety and tolerability of ertapenem. J Antimicrob Chemother (in press).
17. Gesser R, Teppler H, McCarroll K, Woods G. Efficacy of ertapenem in treatment of Escherichia coli infections [abstr P774]. Clin Microbiol Infect 2002; 8 (Suppl. 1): 160.
18. Teppler H, McCarroll K, Gesser RM, Woods GL. Surgical infections with Enterococcus: Outcome in patients treated with ertapenem versus piperacillin-tazobactam. Surg Infect 2002; 3: 337-49.
19. Barie PS, Vogel SB, Dellinger EP, et al. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Arch Surg 1997; 132: 1294-1302.
20. Burnett RJ, Haverstock DC, Dellinger EP, et al. Definition of the role of enterococcus in intraabdominal infection: Analysis of a prospective randomized trial. Surgery 1995; 118: 716-23.
21. Wilson SE, Faulkner K, Biol C, Biol MI. Impact of anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections. Am Surg 1998; 64: 402-7.